Clinical Trials Directory

Trials / Unknown

UnknownNCT03520608

Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt

Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt (PDN-SCOPE): a Multi-center Cross-sectional Registry Study of Clinical Characteristics and Treatment Survey of PDN in China

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Painful Diabetic peripheral Neuropathy Study of Chinese OutPatiEnt (PDN-SCOPE): a multi-center cross-sectional registry study of clinical characteristics and treatment survey of PDN in China

Detailed description

Painful diabetic peripheral neuropathy (PDN) presents a serious health problem in China. SCOPE is a cross-sectional, multi-centers registry study with a target sample size of 1500 patients who are experiencing PDN. The patients are treated following guideline and local practice. Real-world data including demographics, medical histories, VAS, PHQ, GAD -7 and therapies are collected. The primary objective is to analyze the clinical characteristics of PDN. The secondary objectives include anxiety depression distribution and current treatment status.The SCOPE study will help to find actual clinical manifestation and treatment and improve the overall treatment outcome of Chinese patients with PDN.

Conditions

Timeline

Start date
2018-05-01
Primary completion
2018-11-01
Completion
2019-05-01
First posted
2018-05-11
Last updated
2018-05-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03520608. Inclusion in this directory is not an endorsement.